The scope of the Committee shall be the development of standardized nomenclature and definitions of terms, test methods, specifications, and performance standards for the manufacture of pharmaceutical and biopharmaceutical products. The Committee will encourage research in this field and sponsor symposia, workshops, and publications to facilitate the development of such standards. The Committee will promote liaison with other ASTM Committees and other organizations with mutual interests.
helium testing; pressure decay testing; flow testing; integrity assurance; integrity testing; leak testing; liquid leak; microbial ingress; pressure decay testing; single-use system (SUS); single-use system integrity (SUSI); single-use system integrity testing (SUSIT)
This should be a complementary standard to E3244 and E3251, where it is placed in parallel to E3251 and below E3244 in the document hierarchy. It should be used by SUS suppliers and end users to develop and validate physical leak and integrity testing methods for SUS. Also, regulatory bodies can use this test method to facilitate the discussion related to integrity assurance with (bio) pharmaceutical companies.
The title and scope are in draft form and are under development within this ASTM Committee.
Date Initiated: 10-20-2020
Technical Contact: Marc Hogreve